PRMT5 and neoplasm: SIRT7 catalyzes the desuccinylation of PRMT5, thereby augmenting its methyltransferase activity and inhibiting its ubiquitination [50], thereby promoting lipid metabolic reprogramming, tumor growth, and tumor metastasis in HCC.